Correlation Between HLS Therapeutics and Integrated Cannabis
Can any of the company-specific risk be diversified away by investing in both HLS Therapeutics and Integrated Cannabis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HLS Therapeutics and Integrated Cannabis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HLS Therapeutics and Integrated Cannabis Solutions, you can compare the effects of market volatilities on HLS Therapeutics and Integrated Cannabis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HLS Therapeutics with a short position of Integrated Cannabis. Check out your portfolio center. Please also check ongoing floating volatility patterns of HLS Therapeutics and Integrated Cannabis.
Diversification Opportunities for HLS Therapeutics and Integrated Cannabis
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between HLS and Integrated is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding HLS Therapeutics and Integrated Cannabis Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Cannabis and HLS Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HLS Therapeutics are associated (or correlated) with Integrated Cannabis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Cannabis has no effect on the direction of HLS Therapeutics i.e., HLS Therapeutics and Integrated Cannabis go up and down completely randomly.
Pair Corralation between HLS Therapeutics and Integrated Cannabis
Assuming the 90 days horizon HLS Therapeutics is expected to under-perform the Integrated Cannabis. But the pink sheet apears to be less risky and, when comparing its historical volatility, HLS Therapeutics is 4.02 times less risky than Integrated Cannabis. The pink sheet trades about -0.03 of its potential returns per unit of risk. The Integrated Cannabis Solutions is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 0.05 in Integrated Cannabis Solutions on August 26, 2024 and sell it today you would earn a total of 0.32 from holding Integrated Cannabis Solutions or generate 640.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
HLS Therapeutics vs. Integrated Cannabis Solutions
Performance |
Timeline |
HLS Therapeutics |
Integrated Cannabis |
HLS Therapeutics and Integrated Cannabis Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with HLS Therapeutics and Integrated Cannabis
The main advantage of trading using opposite HLS Therapeutics and Integrated Cannabis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HLS Therapeutics position performs unexpectedly, Integrated Cannabis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Cannabis will offset losses from the drop in Integrated Cannabis' long position.HLS Therapeutics vs. Aion Therapeutic | HLS Therapeutics vs. Cannara Biotech | HLS Therapeutics vs. Knight Therapeutics | HLS Therapeutics vs. Canntab Therapeutics Limited |
Integrated Cannabis vs. Speakeasy Cannabis Club | Integrated Cannabis vs. City View Green | Integrated Cannabis vs. Benchmark Botanics | Integrated Cannabis vs. Ravenquest Biomed |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Global Correlations Find global opportunities by holding instruments from different markets | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |